Cytokinetics (CYTK) Misses Q3 EPS by 98c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $74.13 +0.93%
Financial Fact:
Research and development: 19.34M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 19.34M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($2.55), $0.98 worse than the analyst estimate of ($1.57). Revenue for the quarter came in at $1.93 million versus the consensus estimate of $6.05 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Stripe, Advent In Talks To Buy Paypal - WSJ
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
